FourThought Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.08M Buy
5,899
+323
+6% +$330K 0.55% 51
2026
Q1
$5.13M Buy
5,576
+124
+2% +$126K 0.44% 65
2025
Q4
$5.86M Buy
5,452
+19
+0.3% +$18.2K 0.49% 58
2025
Q3
$4.15M Buy
5,433
+2,273
+72% +$1.69M 0.36% 71
2025
Q2
$2.46M Buy
3,160
+839
+36% +$652K 0.24% 92
2025
Q1
$1.92M Buy
2,321
+24
+1% +$20K 0.2% 102
2024
Q4
$1.77M Buy
+2,297
New +$1.9M 0.18% 106
2024
Q2
– Sell
-2,211
Closed -$1.72M – 260
2024
Q1
$1.72M Sell
2,211
-682
-24% -$485K 0.2% 103
2023
Q4
$1.69M Buy
2,893
+4
+0.1% +$2.33K 0.21% 97
2023
Q3
$1.55M Buy
2,889
+10
+0.3% +$5.15K 0.22% 94
2023
Q2
$1.35M Sell
2,879
-139
-5% -$58.3K 0.18% 99
2023
Q1
$1.04M Buy
3,018
+465
+18% +$157K 0.14% 122
2022
Q4
$934K Buy
+2,553
New +$905K 0.14% 129

Other funds holding LLY

FourThought Financial Partners's LLY Position: Q2 2026 in Review

FourThought Financial Partners increased its Eli Lilly (LLY) stake by 5.8% in Q2 2026, buying an estimated $330K and bringing the position to 5,899 shares worth $7.08M. The position accounts for 0.55% of the portfolio, ranked #51.

FourThought Financial Partners first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FourThought Financial Partners held 5,899 shares of Eli Lilly worth $7.08M as of Q2 2026.
  • FourThought Financial Partners bought 323 Eli Lilly shares in Q2 2026, an estimated $330K.
  • Eli Lilly made up 0.55% of FourThought Financial Partners's portfolio in Q2 2026, its #51 holding.
  • FourThought Financial Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FourThought Financial Partners's 13F filing for Q2 2026, filed 12 Aug 2026.